ProQR Therapeutics N.V (NASDAQ: PRQR) is -8.68% lower on its value in year-to-date trading and has touched a low of $1.61 and a high of $4.62 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The PRQR stock was last observed hovering at around $2.27 in the last trading session, with the day’s gains setting it 0.15%.
Currently trading at $2.42, the stock is 9.21% and -6.25% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 0.13 million and changing 6.61% at the moment leaves the stock 2.74% off its SMA200. PRQR registered 16.91% gain for a year compared to 6-month gain of 8.04%. The firm has a 50-day simple moving average (SMA 50) of $2.5812 and a 200-day simple moving average (SMA200) of $2.35545.
The stock witnessed a 5.68% loss in the last 1 month and extending the period to 3 months gives it a -39.20%, and is 7.56% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 6.67% over the week and 7.77% over the month.
Profit margin for the company is -134.29%. Distance from 52-week low is 50.31% and -47.62% from its 52-week high. The company has generated returns on investments over the last 12 months (-63.89%).
with sales reaching $6.22M over the same period.The EPS is expected to grow by 7.96% this year, but quarterly earnings will post 110.75% year-over-year. Quarterly sales are estimated to shrink -8.38% in year-over-year returns.
ProQR Therapeutics N.V (PRQR) Top Institutional Holders
The shares outstanding are 81.68M, and float is at 74.28M with Short Float at 1.25%.
The top institutional shareholder in the company is PRIVIUM FUND MANAGEMENT B.V. with over 5.58 million shares valued at $9.21 million. The investor’s holdings represent 6.8416% of the PRQR Shares outstanding. As of 2024-06-30, the second largest holder is ADAGE CAPITAL PARTNERS GP, L.L.C. with 3.63 million shares valued at $$6.02 million to account for 4.4446 of the shares outstanding. The other top investors are ECOR1 CAPITAL, LLC which holds 2.04 million shares representing 2.5043% and valued at over $3.39 million, while M28 CAPITAL MANAGEMENT LP holds 1.2498 of the shares totaling 1.02 million with a market value of $1.69 million.
ProQR Therapeutics N.V (PRQR) Insider Activity
#####
